Abstract
Recent findings have shown that amniotic fluid (AF) could be a putative new source of multipotent stem cells (SC). We investigated whether these human SC could efficiently differentiate into myogenic lineage in vitro and integrate in vivo skeletal muscle in severe combined immunodeficiency (SCID) mice. C/kit immunomagnetic-sorted AF (AF c/kit+) SC were characterized by immunocytochemistry and Southern blotting for myogenic markers (desmin, MyoD). In vitro, AF c/kit+ SC phenotypic conversion into myogenic cells was assayed by myogenic-specific induction media. AF c/kit+ SC without ex vivo manipulation were transplanted into the tibialis anterior (TA) of (SCID) mice. Acquisition of a myogenic-like phenotype (desmin, MyoD) in AF c/kit+ SC was observed after culture in myogenic-specific induction media. In vivo, transplanted AF c/kit+ SC showed an engraftment in the skeletal muscle of SCID mice, but with unexpected tubular glandular tissue-like differentiation. Importantly, no immuno-rejection, inflammatory response or tumorigenicity of these cells was found. Within these experimental conditions, AF c/kit+ SC were able to differentiate into myogenic cells in vitro, but not in vivo after their transplantation into the skeletal muscle of SCID mice. Because AF c/kit+ SC survived and differentiated into tubular gland-like cells after their transplantation in the TA, an ex vivo engagement in myogenic pathway prior their transplantation could favor their differentiation into myogenic cells in vivo.
Similar content being viewed by others
References
Sartore S, Lenzi M, Angelini A, Chiavegato A, Gasparotto L, De Coppi P et al (2005) Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes. Eur J Cardiothorac Surg 28(5):677–684
Atala A (2006) Recent developments in tissue engineering and regenerative medicine. Curr Opin Pediatr 18(2):167–171
Dai W, Hale SL, Kloner RA (2005) Stem cell transplantation for the treatment of myocardial infarction. Transpl Immunol 15(2):91–97
De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L et al (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25(1):100–106
Hipp J, Atala A (2008) Sources of stem cells for regenerative medicine. Stem Cell Rev 4(1):3–11
Waese EY, Kandel RR, Stanford WL (2008) Application of stem cells in bone repair. Skeletal Radiol 37(7):601–608
Kim J, Lee Y, Kim H, Hwang KJ, Kwon HC, Kim SK et al (2007) Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 40(1):75–90
Segers VF, Lee RT (2008) Stem-cell therapy for cardiac disease. Nature 451(7181):937–942
In’t Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, Willemze R et al (2003) Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102(4):1548–1549
Pan GJ, Chang ZY, Scholer HR, Pei D (2002) Stem cell pluripotency and transcription factor Oct4. Cell Res 12(5–6):321–329
Pesce M, Scholer HR (2001) Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19(4):271–278
Chiavegato A, Bollini S, Pozzobon M, Callegari A, Gasparotto L, Taiani J et al (2007) Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. J Mol Cell Cardiol 42(4):746–759
Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL et al (1990) Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63(1):213–224
Delo DM, De Coppi P, Bartsch G Jr, Atala A (2006) Amniotic fluid and placental stem cells. Methods Enzymol 419:426–438
Parolini O, Alviano F, Bagnara GP, Bilic G, Buuhring HJ, Evangelista M et al (2008) Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26(2):300–311
Tsai MS, Hwang SM, Tsai YL, Cheng FC, Lee JL, Chang YJ (2006) Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 74(3):545–551
Harris RA, Washington AE, Nease RF Jr, Kuppermann M (2004) Cost utility of prenatal diagnosis and the risk-based threshold. Lancet 363(9405):276–282
Mann K, Donaghue C, Fox SP, Docherty Z, Ogilvie CM (2004) Strategies for the rapid prenatal diagnosis of chromosome aneuploidy. Eur J Hum Genet 12(11):907–915
Régie de l'Assurance Maladie du Québec RdlamdQ (2003) Nombres d’amniocentèses pratiquées annuellement dans la province de Québec. Québec (Canada)
Miki T, Lehmann T, Cai H, Stolz DB, Strom SC (2005) Stem cell characteristics of amniotic epithelial cells. Stem Cells 23(10):1549–1559
Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18(4):399–404
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145–1147
De Coppi P, Callegari A, Chiavegato A, Gasparotto L, Piccoli M, Taiani J et al (2007) Amniotic fluid and bone marrow-derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol 177(1):369–376
Quenneville SP, Chapdelaine P, Skuk D, Paradis M, Goulet M, Rousseau J et al (2007) Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models. Mol Ther 15(2):431–438
Walther G, Bertrand O, Gekas J (2009) Amniotic stem cells for cellular cardiomyoplasty: promises and premises. Catheter Cardiovasc Interv 73:917–924
Zhao P, Ise H, Hongo M, Ota M, Konishi I, Nikaido T (2005) Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 79(5):528–535
Andres V, Walsh K (1996) Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 132(4):657–666
Bober E, Lyons GE, Braun T, Cossu G, Buckingham M, Arnold HH (1991) The muscle-regulatory gene, Myf-6, has a biphasic pattern of expression during early mouse development. J Cell Biol 113(6):1255–1265
Dezawa M, Ishikawa H, Itokazu Y, Yoshihara T, Hoshino M, Takeda S et al (2005) Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309(5732):314–317
Challier JC, Galtier M, Cortez A, Bintein T, Rabreau M, Uzan S (2005) Immunocytological evidence for hematopoiesis in the early human placenta. Placenta 26(4):282–288
Ditadi A, de Coppi P, Picone O, Gautreau L, Smati R, Six E et al (2009) Human and murine amniotic fluid c-Kit+ Lin− cells display hematopoietic activity. Blood 113(17):3953–3960
Cascalho M, Ogle BM, Platt JL (2006) The future of organ transplantation. Ann Transplant 11(2):44–47
Fujii I, Matsukura M, Ikezawa M, Suzuki S, Shimada T, Miike T (2006) Adenoviral-mediated MyoD gene transfer into fibroblasts: myogenic disease diagnosis. Brain Dev 28(7):420–425
Tsai MS, Lee JL, Chang YJ, Hwang SM (2004) Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 19(6):1450–1456
D’Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC (2004) Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117(Pt 14):2971–2981
Stenderup K, Justesen J, Clausen C, Kassem M (2003) Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33(6):919–926
Acknowledgments
We are grateful to J. Puymirat, MD, PhD, for his support in this ongoing multidisciplinary project. We also thank J. Leroy for his excellent technical assistance. G. Walther was supported with a post-doctoral grant from Quebec Foundation for Health Research. O.F. Bertrand is a research scholar from Quebec Foundation for Health Research.
Conflict of interest statement
The authors declare that they have no conflict of interest related to the publication of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gekas, J., Walther, G., Skuk, D. et al. In vitro and in vivo study of human amniotic fluid-derived stem cell differentiation into myogenic lineage. Clin Exp Med 10, 1–6 (2010). https://doi.org/10.1007/s10238-009-0060-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10238-009-0060-2